FDA Inspection
Janssen Pharmaceutica, N.V.Janssen Pharmaceutica, N.V. – FDA Inspection, Sep 5, 2025
Record Details
This FDA Inspection record concerns Janssen Pharmaceutica, N.V., with an inspection on September 5, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 32ca5402-5a1e-4e6e-9991-e79d82352d96
Inspection Facts
- Inspection number
- 1270321
- FDA center
- Human Drugs
Other FDA inspections of Janssen Pharmaceutica, N.V.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | Not classified | Office of Inspections and Investigations | |
| May 12, 2025 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 2, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 12, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 1, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Janssen Pharmaceutica, N.V.
- FDA Inspection 1290376 - 2025-11-21
- FDA Inspection 1296030 - 2025-05-12
- FDA Inspection 1203728 - 2021-07-02
- FDA Inspection 1055920 - 2018-06-12
- FDA Inspection 964766 - 2016-03-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.